ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares traded up 0.8% during trading on Monday . The company traded as high as C$6.70 and last traded at C$6.50. 19,980 shares were traded during mid-day trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The company has a market cap of C$162.08 million and a price-to-earnings ratio of -7.30. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The company has a fifty day moving average of C$6.50 and a two-hundred day moving average of C$6.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Energy Transfer: Powering Data With Dividends and Diversification
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Qualcomm Stock Is Coiling for a Breakout
- Using the MarketBeat Stock Split Calculator
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
